RxSight, Inc. to Report First Quarter 2022 Financial Results on May 5, 2022
April 21 2022 - 3:05PM
(NASDAQ: RXST) – April 21, 2022 – RxSight, Inc.,
an ophthalmic medical device company dedicated to improving the
vision of patients following cataract surgery, today announced that
it will report financial results for the first quarter 2022 after
the market close on Thursday, May 5, 2022. The company’s management
will discuss the results during a conference call beginning at 1:30
p.m. Pacific Time / 4:30 p.m. Eastern Time.
Investors interested in listening to the conference call may do
so by accessing a live and archived webcast of the event at
www.rxsight.com, on the Investors page in the News and Events
section. The call will also be available by dialing 877-545-0523
(U.S.) or 973-528-0016 (International) five to ten minutes prior to
the start time, using conference ID: 217735.
About RxSight, Inc.RxSight, Inc. is a
commercial-stage medical technology company dedicated to improving
the vision of patients following cataract surgery. The RxSight®
Light Adjustable Lens system, comprised of the RxSight Light
Adjustable Lens® (LAL®), RxSight Light Delivery Device (LDD™) and
accessories, is the first and only commercially available
intraocular lens (IOL) technology that enables doctors to customize
and optimize visual acuity for patients after cataract surgery. The
LAL now features ActivShield™ technology, a revolutionary UV
protection layer built into the lens. Additional information about
RxSight can be found at www.rxsight.com.
Investor Relations Contact:Philip Taylor
Gilmartin Group415.937.5406IR@rxsight.com
Company Contact:Shelley ThunenChief Financial
OfficerIR@rxsight.com
RxSight (NASDAQ:RXST)
Historical Stock Chart
From Jun 2024 to Jul 2024
RxSight (NASDAQ:RXST)
Historical Stock Chart
From Jul 2023 to Jul 2024